MATEON THERAPEUTICS INC Note Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Oncotelic Therapeutics, Inc. 16% Convertible Unsecured Note Agreement (2023-2025)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2023
Convertible Promissory Note
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
2022
Convertible Promissory Note
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
2022
Unsecured Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2022
Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2022
Oncotelic Therapeutics, Inc. Convertible Promissory Note with Confession of Judgment Provision
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Unsecured Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC dated October 25, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC (October 25, 2021)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Unsecured Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC dated September 21, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Lenders (August 4, 2021)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Oncotelic Therapeutics, Inc. Convertible Promissory Note dated August 4, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Geneva Roth Remark Holdings, Inc. dated May 25, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2021
Common Stock Purchase Warrant Agreement between Mateon Therapeutics, Inc. and Holder
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Secured Convertible Promissory Note between Mateon Therapeutics, Inc. and Golden Mountain Partners, LLC dated June 27, 2020
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Mateon Therapeutics, Inc. 16% Convertible Unsecured Note Agreement with Payee
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Mateon Therapeutics, Inc. 16% Convertible Unsecured Note Due 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Paycheck Protection Program Promissory Note between Mateon Therapeutics, Inc. and Silicon Valley Bank
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Note Purchase Agreement between Mateon Therapeutics, Inc. and Lenders (November 2019)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2019
Mateon Therapeutics, Inc. Convertible Promissory Note Issued Under Note Purchase Agreement (November 23, 2019)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2019
Note Purchase Agreement between Mateon Therapeutics, Inc. and Pointr Data Inc. dated July 22, 2019
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Convertible Promissory Note between Mateon Therapeutics, Inc. and Pointr Data Inc. dated July 22, 2019
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019